Trial intelligence / Profile preview

Effect of Insulin Glulisine vs Insulin Lispro on Postprandial Glucose in Obese Type 2 Diabetes

2005-005914-18Phase 4Active

Sponsor
Diabetes-Zentrum Quakenbrück
Start
Jan 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of human insulin in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Diabetes-Zentrum Quakenbrück. Primary endpoint: Area under the curve (AUC) plasma glucose 0–1 h. Started Jan 2006; status: active.

02

Drugs

human insulin
03

Conditions

type 2 diabetes mellitus (T2DM)obesity

Beyond the preview

Go deeper on 2005-005914-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005914-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call